AlphaQuest’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,932
Closed -$259K 1456
2025
Q4
$259K Buy
6,932
+138
+2% +$5.61K 0.01% 1306
2025
Q3
$275K Buy
6,794
+5,069
+294% +$167K 0.02% 1219
2025
Q2
$44.1K Sell
1,725
-1,838
-52% -$40.1K ﹤0.01% 1650
2025
Q1
$76.1K Sell
3,563
-3,349
-48% -$74.8K 0.01% 1406
2024
Q4
$145K Sell
6,912
-3,669
-35% -$84.9K 0.02% 987
2024
Q3
$238K Buy
10,581
+230
+2% +$4.44K 0.02% 994
2024
Q2
$174K Sell
10,351
-4,012
-28% -$64.5K 0.02% 794
2024
Q1
$186K Buy
14,363
+9,526
+197% +$114K 0.03% 662
2023
Q4
$56K Buy
+4,837
New +$54.6K 0.01% 870

Other funds holding PAHC

AlphaQuest's PAHC Position: Q1 2026 in Review

AlphaQuest sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 6,932 shares — an estimated $259K sold.

AlphaQuest first reported a position in PAHC in Q4 2023 and held it in 9 quarters. The position peaked at $275K in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • AlphaQuest reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 6,932 Phibro Animal Health shares in Q1 2026, an estimated $259K.
  • AlphaQuest first reported a position in Phibro Animal Health in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Phibro Animal Health position peaked at $275K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.